ArticleThe British journal of dermatologyPublished
Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- The British journal of dermatology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Neoplasms; Psoriasis; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Antibodies, Monoclonal, Humanized; Adalimumab
- PubMed ID
- 36944555
- Added to directory
- Source checked